CSIMarket


Terms Beginning with R
       
       
 

Radiolabeling

Health Care Term


Radiolabeling is a process in which a small amount of radioactive materials is attached or "labeled" to a molecule, drug, or protein to allow for its tracking and visualization in the body using imaging technologies such as PET (positron-emission tomography) and SPECT (single-photon emission computed tomography).

In the healthcare industry, radiolabeling plays a critical role in the development and evaluation of new drugs and treatments. It allows researchers and clinicians to track the behavior of these substances in the body, gain insight into their pharmacokinetics (the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body), and identify potential safety issues.

Radiolabeled drugs and biomolecules can also be used for diagnosis and disease staging in various areas of medicine, including oncology, cardiology, neurology, and immunology. For instance, radiolabeled glucose (FDG) is commonly used as a tracer in PET imaging to detect and monitor cancer cells, while radiolabeled antibodies or peptides can target specific receptors or proteins in the body to visualize and quantify disease activity.

Overall, radiolabeling is a powerful tool for enhancing our understanding of biological systems and developing new therapies for a wide range of health conditions.


   
     

Radiolabeling

Health Care Term


Radiolabeling is a process in which a small amount of radioactive materials is attached or "labeled" to a molecule, drug, or protein to allow for its tracking and visualization in the body using imaging technologies such as PET (positron-emission tomography) and SPECT (single-photon emission computed tomography).

In the healthcare industry, radiolabeling plays a critical role in the development and evaluation of new drugs and treatments. It allows researchers and clinicians to track the behavior of these substances in the body, gain insight into their pharmacokinetics (the study of how drugs are absorbed, distributed, metabolized, and eliminated by the body), and identify potential safety issues.

Radiolabeled drugs and biomolecules can also be used for diagnosis and disease staging in various areas of medicine, including oncology, cardiology, neurology, and immunology. For instance, radiolabeled glucose (FDG) is commonly used as a tracer in PET imaging to detect and monitor cancer cells, while radiolabeled antibodies or peptides can target specific receptors or proteins in the body to visualize and quantify disease activity.

Overall, radiolabeling is a powerful tool for enhancing our understanding of biological systems and developing new therapies for a wide range of health conditions.


Related Health Care Terms
                     
                     
 Adenocarcinoma   Analogues   Arrhythmia  
 Adenosine   ANDA Abbreviated New Drug Application   Arteriosclerosis  
 Adult Stem Cell   Angina   Atherosclerosis  
 Adverse Event   Angiogenesis   Autologous  
 Agonist   Angioplasty   Balloon Angioplasty  
 AIDS   Antagonist   Bioavailability  
 Alkylation Agent   Anti Hypertensive   Biologic Products  
 Allogeneic   Antibody   Biomarker  
 Amino Acid   Antigen   Bradycardia  
 Analgesic   API   Cancer  
               
                  next arrow
 
   


Help

About us

Advertise